AU6518298A - Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient - Google Patents

Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient

Info

Publication number
AU6518298A
AU6518298A AU65182/98A AU6518298A AU6518298A AU 6518298 A AU6518298 A AU 6518298A AU 65182/98 A AU65182/98 A AU 65182/98A AU 6518298 A AU6518298 A AU 6518298A AU 6518298 A AU6518298 A AU 6518298A
Authority
AU
Australia
Prior art keywords
novel
active ingredient
vaccines containing
recombinant dna
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65182/98A
Inventor
Takanori Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zeon Co Ltd filed Critical Nippon Zeon Co Ltd
Publication of AU6518298A publication Critical patent/AU6518298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU65182/98A 1997-03-28 1998-03-26 Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient Abandoned AU6518298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9487597 1997-03-28
JP9-94875 1997-03-28
PCT/JP1998/001358 WO1998044093A1 (en) 1997-03-28 1998-03-26 Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient

Publications (1)

Publication Number Publication Date
AU6518298A true AU6518298A (en) 1998-10-22

Family

ID=14122232

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65182/98A Abandoned AU6518298A (en) 1997-03-28 1998-03-26 Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient

Country Status (3)

Country Link
JP (1) JP3924328B2 (en)
AU (1) AU6518298A (en)
WO (1) WO1998044093A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE253123T1 (en) * 1991-08-26 2003-11-15 Baxter Healthcare Sa A RECOMBINANT BIRD POX VIRUS CONTAINING AN INTACT FPV-TK GENE
AU729518B2 (en) * 1995-06-07 2001-02-01 Syntro Corporation Recombinant fowlpox viruses and uses thereof

Also Published As

Publication number Publication date
WO1998044093A1 (en) 1998-10-08
JP3924328B2 (en) 2007-06-06

Similar Documents

Publication Publication Date Title
HK1016218A1 (en) Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv.
AU6443298A (en) Self-assembling genes, vectors and uses thereof
AU1124499A (en) Human papillomavirus vectors
AU4594996A (en) Recombinant alphavirus vectors
IL195649A0 (en) Compositions comprising anti-??v??3 recombinant human antibodies and nucleic acids encoding the same
ZA975943B (en) Aqueous formulations of peptides.
IL128882A0 (en) Viral vectors and their uses
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
AU3423695A (en) Novel sunscreens, photoprotective cosmetic compositions containing them and uses thereof
AU3119895A (en) Recombinant virus vectors
AU6729198A (en) Cosmetic preparations
GB9721909D0 (en) Gene delivery vectors and their uses
AU3309997A (en) Recombinant adeno-associated viral vectors
AU3423795A (en) Novel sunscreens, photoprotective cosmetic compositions containing them and uses thereof
AU7077898A (en) Recombinant vectors derived from adeno-associated virus suitable for gene therapy
HK1052436A1 (en) Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same
PL337757A1 (en) Novel lyposomic vectors of an active ingredient
AU634773B2 (en) Spheroidin dna isolate and recombinant entomopoxvirus expression vectors
HUP9802587A3 (en) Glucose-inducible recombinant viral vector, pharmaceutical composition containing it and cells transformed by this
GB2316681B (en) Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
AU3611495A (en) Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating
AU6518298A (en) Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient
AU8392698A (en) Novel bacteriocins, transport and vector system and method of use thereof
IL144692A0 (en) Insect viral vectors and uses thereof
AU6000500A (en) Virus vectors and preparations and their uses